pregabalin withdrawal treatment

Appropriate treatment for withdrawal from pregabalin involves a gradual dose reduction to minimise withdrawal symptoms and avoid abrupt discontinuation.

• Withdrawal symptoms such as insomnia, headache, nausea, anxiety, diarrhoea, flu syndrome, nervousness, depression, suicidal ideation, pain, convulsions, hyperhidrosis, and dizziness may occur after stopping pregabalin, which can indicate drug dependence. Patients should be informed of these risks at treatment initiation.
• Pregabalin should be discontinued gradually over a minimum of 1 week regardless of indication, with the pace of reduction tailored to the patient’s clinical situation and tolerability. In cases of long-term high-dose use, withdrawal symptoms may be more severe and dose-related.
• Clinical judgement is needed to balance the risk of ongoing exposure with the risk of withdrawal symptoms. Withdrawal may take several months and support should be available throughout the process.
• If distressing withdrawal symptoms occur, consider delaying dose reductions, making smaller decrements, or reverting to the previous dose.
• A prior discussion with the patient should establish a withdrawal strategy before starting pregabalin.
• The underlying condition for which pregabalin was prescribed should continue to be managed during withdrawal if needed.
• Do not treat withdrawal symptoms with another medicine that also carries dependence risk.

Overall, a slow, individualized tapering regimen with close monitoring and patient support is the recommended approach for managing pregabalin withdrawal.